Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)
Hong Kong
· Delayed Price · Currency is HKD
1.790
0.00 (0.00%)
At close: Sep 5, 2024
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 5,747 | 8,057 | 7,767 | 13,434 | 15,730 | 4,117 | |
Market Cap Growth | -26.78% | 3.73% | -42.18% | -14.60% | 282.12% | 14.07% | |
Enterprise Value | 4,448 | 6,850 | 6,427 | 12,106 | 14,244 | 3,733 | |
Last Close Price | 1.74 | 2.41 | 3.19 | 3.45 | 3.38 | 3.89 | |
PE Ratio | 15.17 | 20.85 | 21.71 | 14.06 | 17.10 | 14.12 | |
PS Ratio | 2.28 | 8.60 | 6.66 | 9.60 | 15.89 | 3.58 | |
PB Ratio | 0.71 | 3.10 | 3.05 | 5.00 | 6.59 | 3.94 | |
P/FCF Ratio | 10.88 | -261.63 | 88.13 | 73.56 | 187.64 | 16.08 | |
P/OCF Ratio | 24.54 | 102.98 | 41.57 | 40.70 | 117.21 | 13.67 | |
EV/Sales Ratio | 5.62 | 7.31 | 5.51 | 8.65 | 14.38 | 3.24 | |
EV/EBITDA Ratio | 34.81 | 50.62 | 30.41 | 45.55 | 62.59 | 11.83 | |
EV/EBIT Ratio | 59.92 | 80.59 | 49.83 | 60.61 | 84.03 | 14.45 | |
EV/FCF Ratio | 26.83 | -222.45 | 72.92 | 66.29 | 169.90 | 14.58 | |
Debt / Equity Ratio | 0.01 | 0.01 | 0.06 | 0.01 | 0.01 | 0.17 | |
Debt / EBITDA Ratio | 0.10 | 0.13 | 0.64 | 0.14 | 0.10 | 0.54 | |
Debt / FCF Ratio | 0.08 | -0.62 | 1.60 | 0.21 | 0.28 | 0.68 | |
Asset Turnover | 0.25 | 0.29 | 0.36 | 0.43 | 0.41 | 0.68 | |
Inventory Turnover | 1.21 | 1.76 | 2.27 | 2.26 | 1.95 | 2.41 | |
Quick Ratio | 3.72 | 3.60 | 2.98 | 3.56 | 4.63 | 1.90 | |
Current Ratio | 3.88 | 3.70 | 3.07 | 3.65 | 4.74 | 1.99 | |
Return on Equity (ROE) | 4.72% | 4.70% | 6.18% | 10.12% | 11.17% | 23.38% | |
Return on Assets (ROA) | 1.47% | 1.65% | 2.48% | 3.85% | 4.39% | 9.52% | |
Return on Capital (ROIC) | 1.80% | 2.03% | 3.10% | 4.79% | 5.73% | 13.17% | |
Earnings Yield | 6.59% | 1.49% | 2.01% | 1.95% | 1.24% | 6.18% | |
FCF Yield | 9.19% | -0.38% | 1.13% | 1.36% | 0.53% | 6.22% | |
Dividend Yield | 2.46% | 3.20% | 2.48% | 2.49% | 1.76% | 2.01% | |
Payout Ratio | 68.81% | 70.10% | 51.48% | 24.45% | 42.37% | 30.88% | |
Buyback Yield / Dilution | -0.98% | -0.28% | 1.30% | -5.59% | -7.20% | - | |
Total Shareholder Return | 1.48% | 2.91% | 3.78% | -3.11% | -5.44% | 2.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.